Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
Global Gene Cell Therapy CDMO Market Growth (Status and Outlook) 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Gene Cell Therapy CDMO Market Size 2019-2030 2.1.2 Gene Cell Therapy CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) 2.1.3 World Current & Future Analysis for Gene Cell Therapy CDMO by Country/Region, 2019, 2023 & 2030 2.2 Gene Cell Therapy CDMO Segment by Type 2.2.1 Immune Cells 2.2.2 Stem Cell 2.2.3 Viral Vector 2.2.4 Plasmid DNA 2.3 Gene Cell Therapy CDMO Market Size by Type 2.3.1 Gene Cell Therapy CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024) 2.4 Gene Cell Therapy CDMO Segment by Application 2.4.1 Pharmaceutical and Biotechnology Companies 2.4.2 Research and Academic Institutions 2.4.3 Hospital 2.4.4 Others 2.5 Gene Cell Therapy CDMO Market Size by Application 2.5.1 Gene Cell Therapy CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024) 3 Gene Cell Therapy CDMO Market Size by Player 3.1 Gene Cell Therapy CDMO Market Size Market Share by Player 3.1.1 Global Gene Cell Therapy CDMO Revenue by Player (2019-2024) 3.1.2 Global Gene Cell Therapy CDMO Revenue Market Share by Player (2019-2024) 3.2 Global Gene Cell Therapy CDMO Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Gene Cell Therapy CDMO by Region 4.1 Gene Cell Therapy CDMO Market Size by Region (2019-2024) 4.2 Global Gene Cell Therapy CDMO Annual Revenue by Country/Region (2019-2024) 4.3 Americas Gene Cell Therapy CDMO Market Size Growth (2019-2024) 4.4 APAC Gene Cell Therapy CDMO Market Size Growth (2019-2024) 4.5 Europe Gene Cell Therapy CDMO Market Size Growth (2019-2024) 4.6 Middle East & Africa Gene Cell Therapy CDMO Market Size Growth (2019-2024) 5 Americas 5.1 Americas Gene Cell Therapy CDMO Market Size by Country (2019-2024) 5.2 Americas Gene Cell Therapy CDMO Market Size by Type (2019-2024) 5.3 Americas Gene Cell Therapy CDMO Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Gene Cell Therapy CDMO Market Size by Region (2019-2024) 6.2 APAC Gene Cell Therapy CDMO Market Size by Type (2019-2024) 6.3 APAC Gene Cell Therapy CDMO Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024) 7.2 Europe Gene Cell Therapy CDMO Market Size by Type (2019-2024) 7.3 Europe Gene Cell Therapy CDMO Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Gene Cell Therapy CDMO by Region (2019-2024) 8.2 Middle East & Africa Gene Cell Therapy CDMO Market Size by Type (2019-2024) 8.3 Middle East & Africa Gene Cell Therapy CDMO Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Gene Cell Therapy CDMO Market Forecast 10.1 Global Gene Cell Therapy CDMO Forecast by Region (2025-2030) 10.1.1 Global Gene Cell Therapy CDMO Forecast by Region (2025-2030) 10.1.2 Americas Gene Cell Therapy CDMO Forecast 10.1.3 APAC Gene Cell Therapy CDMO Forecast 10.1.4 Europe Gene Cell Therapy CDMO Forecast 10.1.5 Middle East & Africa Gene Cell Therapy CDMO Forecast 10.2 Americas Gene Cell Therapy CDMO Forecast by Country (2025-2030) 10.2.1 United States Market Gene Cell Therapy CDMO Forecast 10.2.2 Canada Market Gene Cell Therapy CDMO Forecast 10.2.3 Mexico Market Gene Cell Therapy CDMO Forecast 10.2.4 Brazil Market Gene Cell Therapy CDMO Forecast 10.3 APAC Gene Cell Therapy CDMO Forecast by Region (2025-2030) 10.3.1 China Gene Cell Therapy CDMO Market Forecast 10.3.2 Japan Market Gene Cell Therapy CDMO Forecast 10.3.3 Korea Market Gene Cell Therapy CDMO Forecast 10.3.4 Southeast Asia Market Gene Cell Therapy CDMO Forecast 10.3.5 India Market Gene Cell Therapy CDMO Forecast 10.3.6 Australia Market Gene Cell Therapy CDMO Forecast 10.4 Europe Gene Cell Therapy CDMO Forecast by Country (2025-2030) 10.4.1 Germany Market Gene Cell Therapy CDMO Forecast 10.4.2 France Market Gene Cell Therapy CDMO Forecast 10.4.3 UK Market Gene Cell Therapy CDMO Forecast 10.4.4 Italy Market Gene Cell Therapy CDMO Forecast 10.4.5 Russia Market Gene Cell Therapy CDMO Forecast 10.5 Middle East & Africa Gene Cell Therapy CDMO Forecast by Region (2025-2030) 10.5.1 Egypt Market Gene Cell Therapy CDMO Forecast 10.5.2 South Africa Market Gene Cell Therapy CDMO Forecast 10.5.3 Israel Market Gene Cell Therapy CDMO Forecast 10.5.4 Turkey Market Gene Cell Therapy CDMO Forecast 10.6 Global Gene Cell Therapy CDMO Forecast by Type (2025-2030) 10.7 Global Gene Cell Therapy CDMO Forecast by Application (2025-2030) 10.7.1 GCC Countries Market Gene Cell Therapy CDMO Forecast 11 Key Players Analysis 11.1 Catalent 11.1.1 Catalent Company Information 11.1.2 Catalent Gene Cell Therapy CDMO Product Offered 11.1.3 Catalent Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Catalent Main Business Overview 11.1.5 Catalent Latest Developments 11.2 Lonza 11.2.1 Lonza Company Information 11.2.2 Lonza Gene Cell Therapy CDMO Product Offered 11.2.3 Lonza Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Lonza Main Business Overview 11.2.5 Lonza Latest Developments 11.3 Thermo Fisher 11.3.1 Thermo Fisher Company Information 11.3.2 Thermo Fisher Gene Cell Therapy CDMO Product Offered 11.3.3 Thermo Fisher Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Thermo Fisher Main Business Overview 11.3.5 Thermo Fisher Latest Developments 11.4 ACG Biologics 11.4.1 ACG Biologics Company Information 11.4.2 ACG Biologics Gene Cell Therapy CDMO Product Offered 11.4.3 ACG Biologics Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 ACG Biologics Main Business Overview 11.4.5 ACG Biologics Latest Developments 11.5 Charles River 11.5.1 Charles River Company Information 11.5.2 Charles River Gene Cell Therapy CDMO Product Offered 11.5.3 Charles River Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Charles River Main Business Overview 11.5.5 Charles River Latest Developments 11.6 Oxford Biomedica 11.6.1 Oxford Biomedica Company Information 11.6.2 Oxford Biomedica Gene Cell Therapy CDMO Product Offered 11.6.3 Oxford Biomedica Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Oxford Biomedica Main Business Overview 11.6.5 Oxford Biomedica Latest Developments 11.7 Novartis 11.7.1 Novartis Company Information 11.7.2 Novartis Gene Cell Therapy CDMO Product Offered 11.7.3 Novartis Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Novartis Main Business Overview 11.7.5 Novartis Latest Developments 11.8 OBiO 11.8.1 OBiO Company Information 11.8.2 OBiO Gene Cell Therapy CDMO Product Offered 11.8.3 OBiO Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 OBiO Main Business Overview 11.8.5 OBiO Latest Developments 11.9 GenScript 11.9.1 GenScript Company Information 11.9.2 GenScript Gene Cell Therapy CDMO Product Offered 11.9.3 GenScript Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 GenScript Main Business Overview 11.9.5 GenScript Latest Developments 11.10 Pharmaron 11.10.1 Pharmaron Company Information 11.10.2 Pharmaron Gene Cell Therapy CDMO Product Offered 11.10.3 Pharmaron Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Pharmaron Main Business Overview 11.10.5 Pharmaron Latest Developments 11.11 Porton 11.11.1 Porton Company Information 11.11.2 Porton Gene Cell Therapy CDMO Product Offered 11.11.3 Porton Gene Cell Therapy CDMO Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 Porton Main Business Overview 11.11.5 Porton Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Gene Cell Therapy CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions) Table 2. Gene Cell Therapy CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Immune Cells Table 4. Major Players of Stem Cell Table 5. Major Players of Viral Vector Table 6. Major Players of Plasmid DNA Table 7. Gene Cell Therapy CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions) Table 8. Global Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions) Table 9. Global Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024) Table 10. Gene Cell Therapy CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions) Table 11. Global Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions) Table 12. Global Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024) Table 13. Global Gene Cell Therapy CDMO Revenue by Player (2019-2024) & ($ millions) Table 14. Global Gene Cell Therapy CDMO Revenue Market Share by Player (2019-2024) Table 15. Gene Cell Therapy CDMO Key Players Head office and Products Offered Table 16. Gene Cell Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions) Table 20. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024) Table 21. Global Gene Cell Therapy CDMO Revenue by Country/Region (2019-2024) & ($ millions) Table 22. Global Gene Cell Therapy CDMO Revenue Market Share by Country/Region (2019-2024) Table 23. Americas Gene Cell Therapy CDMO Market Size by Country (2019-2024) & ($ millions) Table 24. Americas Gene Cell Therapy CDMO Market Size Market Share by Country (2019-2024) Table 25. Americas Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions) Table 26. Americas Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024) Table 27. Americas Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions) Table 28. Americas Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024) Table 29. APAC Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions) Table 30. APAC Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024) Table 31. APAC Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions) Table 32. APAC Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions) Table 33. Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024) & ($ millions) Table 34. Europe Gene Cell Therapy CDMO Market Size Market Share by Country (2019-2024) Table 35. Europe Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions) Table 36. Europe Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions) Table 37. Middle East & Africa Gene Cell Therapy CDMO Market Size by Region (2019-2024) & ($ millions) Table 38. Middle East & Africa Gene Cell Therapy CDMO Market Size by Type (2019-2024) & ($ millions) Table 39. Middle East & Africa Gene Cell Therapy CDMO Market Size by Application (2019-2024) & ($ millions) Table 40. Key Market Drivers & Growth Opportunities of Gene Cell Therapy CDMO Table 41. Key Market Challenges & Risks of Gene Cell Therapy CDMO Table 42. Key Industry Trends of Gene Cell Therapy CDMO Table 43. Global Gene Cell Therapy CDMO Market Size Forecast by Region (2025-2030) & ($ millions) Table 44. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Region (2025-2030) Table 45. Global Gene Cell Therapy CDMO Market Size Forecast by Type (2025-2030) & ($ millions) Table 46. Global Gene Cell Therapy CDMO Market Size Forecast by Application (2025-2030) & ($ millions) Table 47. Catalent Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 48. Catalent Gene Cell Therapy CDMO Product Offered Table 49. Catalent Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 50. Catalent Main Business Table 51. Catalent Latest Developments Table 52. Lonza Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 53. Lonza Gene Cell Therapy CDMO Product Offered Table 54. Lonza Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 55. Lonza Main Business Table 56. Lonza Latest Developments Table 57. Thermo Fisher Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 58. Thermo Fisher Gene Cell Therapy CDMO Product Offered Table 59. Thermo Fisher Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Thermo Fisher Main Business Table 61. Thermo Fisher Latest Developments Table 62. ACG Biologics Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 63. ACG Biologics Gene Cell Therapy CDMO Product Offered Table 64. ACG Biologics Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. ACG Biologics Main Business Table 66. ACG Biologics Latest Developments Table 67. Charles River Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 68. Charles River Gene Cell Therapy CDMO Product Offered Table 69. Charles River Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Charles River Main Business Table 71. Charles River Latest Developments Table 72. Oxford Biomedica Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 73. Oxford Biomedica Gene Cell Therapy CDMO Product Offered Table 74. Oxford Biomedica Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. Oxford Biomedica Main Business Table 76. Oxford Biomedica Latest Developments Table 77. Novartis Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 78. Novartis Gene Cell Therapy CDMO Product Offered Table 79. Novartis Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. Novartis Main Business Table 81. Novartis Latest Developments Table 82. OBiO Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 83. OBiO Gene Cell Therapy CDMO Product Offered Table 84. OBiO Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. OBiO Main Business Table 86. OBiO Latest Developments Table 87. GenScript Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 88. GenScript Gene Cell Therapy CDMO Product Offered Table 89. GenScript Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. GenScript Main Business Table 91. GenScript Latest Developments Table 92. Pharmaron Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 93. Pharmaron Gene Cell Therapy CDMO Product Offered Table 94. Pharmaron Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 95. Pharmaron Main Business Table 96. Pharmaron Latest Developments Table 97. Porton Details, Company Type, Gene Cell Therapy CDMO Area Served and Its Competitors Table 98. Porton Gene Cell Therapy CDMO Product Offered Table 99. Porton Gene Cell Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 100. Porton Main Business Table 101. Porton Latest Developments List of Figures Figure 1. Gene Cell Therapy CDMO Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Gene Cell Therapy CDMO Market Size Growth Rate 2019-2030 ($ millions) Figure 6. Gene Cell Therapy CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Gene Cell Therapy CDMO Sales Market Share by Country/Region (2023) Figure 8. Gene Cell Therapy CDMO Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Gene Cell Therapy CDMO Market Size Market Share by Type in 2023 Figure 10. Gene Cell Therapy CDMO in Pharmaceutical and Biotechnology Companies Figure 11. Global Gene Cell Therapy CDMO Market: Pharmaceutical and Biotechnology Companies (2019-2024) & ($ millions) Figure 12. Gene Cell Therapy CDMO in Research and Academic Institutions Figure 13. Global Gene Cell Therapy CDMO Market: Research and Academic Institutions (2019-2024) & ($ millions) Figure 14. Gene Cell Therapy CDMO in Hospital Figure 15. Global Gene Cell Therapy CDMO Market: Hospital (2019-2024) & ($ millions) Figure 16. Gene Cell Therapy CDMO in Others Figure 17. Global Gene Cell Therapy CDMO Market: Others (2019-2024) & ($ millions) Figure 18. Global Gene Cell Therapy CDMO Market Size Market Share by Application in 2023 Figure 19. Global Gene Cell Therapy CDMO Revenue Market Share by Player in 2023 Figure 20. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024) Figure 21. Americas Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions) Figure 22. APAC Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions) Figure 23. Europe Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions) Figure 24. Middle East & Africa Gene Cell Therapy CDMO Market Size 2019-2024 ($ millions) Figure 25. Americas Gene Cell Therapy CDMO Value Market Share by Country in 2023 Figure 26. United States Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 27. Canada Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 28. Mexico Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 29. Brazil Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 30. APAC Gene Cell Therapy CDMO Market Size Market Share by Region in 2023 Figure 31. APAC Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024) Figure 32. APAC Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024) Figure 33. China Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 34. Japan Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 35. South Korea Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 36. Southeast Asia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 37. India Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 38. Australia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 39. Europe Gene Cell Therapy CDMO Market Size Market Share by Country in 2023 Figure 40. Europe Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024) Figure 41. Europe Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024) Figure 42. Germany Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 43. France Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 44. UK Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 45. Italy Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 46. Russia Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 47. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Region (2019-2024) Figure 48. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Type (2019-2024) Figure 49. Middle East & Africa Gene Cell Therapy CDMO Market Size Market Share by Application (2019-2024) Figure 50. Egypt Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 51. South Africa Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 52. Israel Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 53. Turkey Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 54. GCC Countries Gene Cell Therapy CDMO Market Size Growth 2019-2024 ($ millions) Figure 55. Americas Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 56. APAC Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 57. Europe Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 58. Middle East & Africa Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 59. United States Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 60. Canada Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 61. Mexico Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 62. Brazil Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 63. China Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 64. Japan Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 65. Korea Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 66. Southeast Asia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 67. India Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 68. Australia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 69. Germany Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 70. France Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 71. UK Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 72. Italy Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 73. Russia Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 74. Egypt Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 75. South Africa Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 76. Israel Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 77. Turkey Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 78. GCC Countries Gene Cell Therapy CDMO Market Size 2025-2030 ($ millions) Figure 79. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Type (2025-2030) Figure 80. Global Gene Cell Therapy CDMO Market Size Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Catalent|||Lonza|||Thermo Fisher|||ACG Biologics|||Charles River|||Oxford Biomedica|||Novartis|||OBiO|||GenScript|||Pharmaron|||Porton